2022 |
Lee LR, Holman AE, Li X, Vasiljevski ER, O'Donohue AK, Cheng TL, Little DG, Schindeler A, Biggin A, Munns CF. Combination treatment with growth hormone and zoledronic acid in a mouse model of osteogenesis imperfecta. Bone. June 2022;159:116378. |
0 |
0 |
2022 |
Vanderniet JA, Wall C-L, Mullins A, London K, Lim L, Hibbert S, Briody J, Padhye B, Poon M, Biggin A, Dalla-Pozza L, Munns CF. Denosumab for central giant cell granuloma in an Australian tertiary paediatric centre. Bone. June 2022;159:116395. |
0 |
0 |
2023 |
O'Donohue AK, Xiao Y, Lee LR, Schofield T, Cheng TL, Munns CF, Baldock PA, Schindeler A. Targeted postnatal knockout of Sclerostin using a bone-targeted adeno-associated viral vector increases bone anabolism and decreases canalicular density. Bone. February 2023;167:116636. |
0 |
0 |
2023 |
Sandy JL, Nunez C, Wheeler BJ, Jefferies C, Morris A, Siafarikas A, Rodda CP, Simm P, Biggin A, Aum S, Elliot EJ, Munns CF. Prevalence and characteristics of paediatric x-linked hypophosphataemia in australia and new zealand: results from the Australian and the New Zealand Paediatric Surveillance Snits survey. Bone. August 2023;173:116791. |
0 |
0 |
2020 |
Morse A, McDonald MM, Mikulec K, Schindeler A, Munns CF, Little DG. Pretreatment with pamidronate decreases bone formation but increases callus bone volume in a rat closed fracture model. Calcif Tiss Int. February 2020;106(2):172-179. |
3 |
2 |
2021 |
Padidela R, Whyte MP, Glorieux FH, Munns CF, Ward LM, Nilsson O, Portale AA, Simmons JH, Namba N, Cheong HI, Pitukcheewanont P, Sochett E, Högler W, Muroya K, Tanaka H, Gottesman GS, Biggin A, Perwad F, Williams A, Nixon A, Sun W, Chen A, Skrinar A, Imel EA. Patient-reported outcomes from a randomized, active-controlled, open-label, phase 3 trial of burosumab versus conventional therapy in children with x-linked hypophosphatemia. Calcif Tiss Int. May 2021;108(5):622-633. |
0 |
0 |
2022 |
Schindeler A, Lee LR, O'Donohue AK, Ginn SL, Munns CF. Curative cell and gene therapy for osteogenesis imperfecta. J Bone Miner Res. May 2022;37(5):826-836. |
0 |
0 |
2023 |
O'Donohue AK, Dao A, Bobyn JD, Munns CF, Little DG, Schindeler A. Modeling anabolic and antiresorptive therapies for fracture healing in a mouse model of osteogenesis imperfecta. J Orthop Res. April 2023;41(4):808-814. |
0 |
0 |